Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
107.63
-5.88 (-5.18%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Celcuity Employees
Celcuity had 155 employees as of December 31, 2025. The number of employees increased by 68 or 78.16% compared to the previous year.
Employees
155
Change (1Y)
68
Growth (1Y)
78.16%
Revenue / Employee
n/a
Profits / Employee
-$1,244,426
Market Cap
5.26B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 155 | 68 | 78.16% |
| Dec 31, 2024 | 87 | 32 | 58.18% |
| Dec 31, 2023 | 55 | 10 | 22.22% |
| Dec 31, 2022 | 45 | 6 | 15.38% |
| Dec 31, 2021 | 39 | 9 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Edgewise Therapeutics | 154 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
| Oruka Therapeutics | 68 |
CELC News
- 4 weeks ago - Celcuity Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Celcuity Slides: FY 2026 - Filings
- 5 weeks ago - Celcuity Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Celcuity prices $500M convertible senior note offering - TheFly
- 5 weeks ago - Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032 - GlobeNewsWire
- 5 weeks ago - Celcuity price target lowered to $171 from $189 at Craig-Hallum - TheFly
- 5 weeks ago - Celcuity price target lowered to $166 from $183 at Wells Fargo - TheFly
- 5 weeks ago - Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032 - GlobeNewsWire